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Research articleAlternative trans-splicing of Caenorhabditis elegans 
sma-9/schnurri generates a short transcript that 
provides tissue-specific function in BMP signaling
Jianghua Yin, Ling Yu and Cathy Savage-Dunn*
Abstract
Background: Transcription cofactors related to Drosophila Schnurri facilitate the transcriptional programs regulated by 
BMP signaling in C. elegans, Drosophila, Xenopus, and mouse. In different systems, Schnurri homologs have been 
shown to act as either agonists or antagonists of Smad function, and as either positive or negative regulators of 
transcription. How Schnurri proteins achieve this diversity of activities is not clear. The C. elegans sma-9/schnurri locus 
undergoes alternative splicing, including an unusual trans-splicing event that could generate two non-overlapping 
shorter transcripts.
Results: We demonstrate here that the shorter transcripts are expressed in vivo. Furthermore, we find that one of the 
short transcripts plays a tissue-specific role in sma-9 function, contributing to the patterning of male-specific sensory 
rays, but not to the regulation of body size. Based on previous results, we suggest that this transcript encodes a C-
terminal SMA-9 isoform that may provide transcriptional activation activity, while full length isoforms may mediate 
transcriptional repression and/or activation in a context-dependent manner.
Conclusion: The alternative trans-splicing of sma-9 may contribute to the diversity of functions necessary to mediate 
tissue-specific outputs of BMP signaling.
Background
The transforming growth factor β (TGFβ) superfamily
comprises a large number of secreted peptide growth fac-
tors that have major regulatory effects on cell growth and
differentiation [1,2]. Members of this superfamily include
the TGFβs, the prototypes of the superfamily; the bone
morphogenetic proteins (BMPs); and other members
such as activin, inhibin, and Nodal. TGFβ superfamily
ligands bind to a heteromeric receptor complex at the cell
surface. This complex contains two related transmem-
brane serine/threonine kinases, the type I and type II
receptors [3,4]. Signaling downstream of the receptors is
mediated by the Smad proteins, which shuttle between
the cytoplasm and nucleus to regulate target gene expres-
sion [5]. Type I receptors directly activate receptor-regu-
lated Smads (R-Smads) by phosphorylation at C-terminal
SXS sequences [6,7]. Phosphorylation of R-Smads pro-
motes heterotrimeric complex formation with Co-Smads
and accumulation in the nucleus to regulate gene tran-
scription [7-11]. In mammals, five R-Smads are present:
two (Smad2,3) that transduce TGFβ/activin/Nodal sig-
nals and three (Smad1,5,8) that transduce BMP signals.
Strikingly, the TGFβ family ligands far outnumber the
Smads available for signal transduction. Furthermore,
many of these ligands are capable of eliciting diverse con-
text-dependent responses. Thus, Smad complexes must
be capable of mediating multiple diverse outcomes. It is
thought that Smad complexes rely in part on transcrip-
tion cofactors for appropriate regulation of target genes.
In the nematode Caenorhabditis elegans, the BMP-
related factor DBL-1 regulates body size and male tail
morphogenesis via a conserved receptor/Smad signaling
pathway [12]. Using a genetic approach to uncover com-
ponents of this pathway, we previously identified sma-9, a
gene that is required for the body size and male tail pat-
terning functions of DBL-1 [13]. sma-9 is also required
for patterning of the mesodermal lineage, in which it acts
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antagonistically to the DBL-1 pathway [14]. sma-9 is pre-
dicted to encode multiple protein products homologous
to Drosophila Schnurri, a large zinc finger transcription
cofactor that functions in Dpp/BMP signaling [15,16].
Analysis of sma-9 therefore provides the opportunity to
elucidate the requirements for transcription cofactor
function in an in vivo model system during the course of
development. In addition to Drosophila Schnurri and C.
elegans SMA-9/Schnurri, three vertebrate Schnurri
homologs have been identified. These bind the κB-bind-
ing site and function in T cell development [17-19]. Nota-
bly, vertebrate Schnurri homologs have more recently
been demonstrated to mediate transcriptional regulation
downstream of BMP and TGFβ ligands, indicating a con-
served role for these family members in TGFβ signal
transduction [20-22].
The sma-9 open reading frame (ORF) predicted from
genomic sequence encodes a protein of 2170 aa consist-
ing of an N-terminal Gln-rich domain (encoded by pre-
dicted exons 1-3) and a C-terminal domain containing
seven Zn fingers (in predicted exons 12-22). The
sequencing of cDNA clones, however, revealed at least
eight different mRNA species with alternative protein
coding regions [13]. Interestingly, like sma-9, human
Shn-1 and Shn-3 genes undergo alternative splicing
[23,24], but the functional consequences of this process-
ing have not been addressed. The sma-9 cDNA clones
were classified based on their potential to code for the
seven C-terminal Zn fingers: class I encodes all seven Zn
fingers (ZF1-7), class II encodes the first pair and the trip-
let of Zn fingers (ZF1-5), and class III encodes only the
first pair (ZF1-2). To determine whether these domains
have different functions in vivo, Foehr et al. created
genomic/cDNA hybrid constructs and tested their ability
to rescue the body size and mesodermal patterning
defects of sma-9 mutants [14]. They found that con-
structs encoding class I and class II C-termini were capa-
ble of rescuing both phenotypes, while the class III
construct was not, suggesting that the presence of the Zn
finger triplet is critical for function in body size and
mesodermal lineage regulation.
Since sma-9 is a large gene, most of the existing cDNA
clones contain incomplete coding sequences that are
missing the 5' end of the gene. Two cDNA clones,
yk1285a11 and yk1237d01, however, are notably different
(Figure 1). Although these two cDNA clones are less than
half the length of the predicted transcript, both of them
have all of the hallmarks of a full-length cDNA: trans-
spliced leader sequence, poly(A) tail, and a complete ORF.
In C. elegans, many transcripts are processed at the 5' end
by trans-splicing, which results in the addition of a 22-
nucleotide splice leader sequence, SL1 or SL2 [25]. The
mechanism of trans-splicing is similar to that of cis-splic-
ing (intron removal), except that the splice donor
sequences are provided by the SL1 and SL2 genes, rather
than being contained within the context of the individual
gene [25]. About half of all C. elegans genes are subjected
to SL1 trans-splicing at the 5' end. A smaller subset of C.
elegans genes are transcribed in polycistronic operons. In
an operon, the 5'-most gene generally receives the SL1
splice leader. The individual downstream genes in an
operon are then separated via SL2 trans-splicing to the 5'
ends of each of the downstream genes. SL2 trans-splicing
is accompanied by polyadenylation to create the 3' end of
the neighboring gene upstream. yk1285a11 contains the
SL1 splice leader and sequences from predicted exons 1-
7. yk1237d01 contains the SL2 splice leader and
sequences from predicted exons 11-25. As previously
noted [13], the putative intercistronic region contains
features reminiscent of the identified signals for trans-
splicing, including a U-rich sequence, but is atypically
long [26,27]. Thus, the structures of the sma-9 cDNA
clones yk1285a11 and yk1237d01 suggest that they may
represent two transcripts processed from a single longer
transcript by SL2 trans-splicing and polyadenylation as
normally occurs in a C. elegans polycistronic operon.
Since each of these trans-spliced short sma-9 tran-
scripts was only represented by a single cDNA clone, we
could not be certain that the clones were not due to clon-
ing artifacts or a rare spurious event. Furthermore, our
previous analysis did not address whether these short
transcripts provide any function required for DBL-1 sig-
nal transduction. We therefore address here several
remaining questions about these predicted transcripts.
First, can we verify that the mRNA variants represented
by yk1285a11 and yk1237d01 are expressed in vivo, rather
than being artifacts produced during cDNA library con-
struction? If so, then how is the expression of these vari-
ants regulated? Finally, do these variants show functional
differences between each other and/or relative to full-
length transcripts in vivo? In this work, we will refer to
the splice variants represented by clones yk1285a11 (5')
and yk1237d01 (3') as A11 and D01, respectively.
Results
Isolation of cDNAs spanning upstream and downstream 
regions
The sma-9 ORF predicted from genomic sequence is
encoded by 25 exons ([13]; Figure 1). Previously charac-
terized cDNA clones, however, contained only a subset of
these 25 exons and, in particular, none of the existing
cDNA clones spanned a region including both the N-ter-
minal Gln-rich domain and the C-terminal Zn finger
domains. We therefore used primers in exons 1 and 25
with the potential to generate nearly full-length cDNA
inserts by RT-PCR. After RT-PCR, the clones with the
longest inserts were selected for sequencing. The most
complete cDNA clone isolated by this approach was
Yin et al. BMC Molecular Biology 2010, 11:46
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pCS368, in which exons 4-8 and part of exon 9 are spliced
out (Figure 1). This transcript form is reminiscent of a
form identified by the ORFeome project, in which exon 3
becomes spliced to exon 20 [28]. These results thus sup-
port the existence of sma-9 transcripts capable of encod-
ing both the Gln-rich and the Zn finger domains.
Additional support derives from RT-PCR data using exon
9 primers (see below).
Expression of sma-9 variant transcripts
We next sought to obtain evidence that the short tran-
scripts represented by cDNA clones yk1285a11 and
yk1237d01 (A11 and D01) are expressed in vivo, rather
than cDNA artifacts. To address this question, we needed
an approach to distinguish these short transcripts from
full-length transcripts containing the same internal
sequences. Unfortunately, we were unable to detect sma-
9 mRNAs by Northern blot (data not shown). Instead, we
used the unique termini of the short transcripts to design
variant-specific primer pairs for RT-PCR. For A11 we
employed an oligo-dT-containing reverse primer
anchored by two nucleotides from sma-9 exon 7 with a
gene-specific internal forward primer; for D01 we used
an SL2-containing primer anchored by two nucleotides
from sma-9 exon 11 with a gene-specific internal reverse
primer. To determine empirically whether these primer
pairs are specific for A11 and D01, we performed RT-
PCR using a gradient of annealing temperatures (50°C -
55°C) and analyzed the products (Figure 2A). In both
cases, the primer pairs amplified a single band of the cor-
rect size (330 bp for A11 and 300 bp for D01), indicating
that the primers specifically detect the desired tran-
scripts. Since the higher annealing temperatures resulted
in reduced yield, we used 50°C for all subsequent analy-
ses. Based on these results, we conclude that transcripts
polyadenylated downstream of exon 7 and transcripts
containing the SL2 splice leader sequence upstream of
exon 11 are represented in the pool of sma-9 mRNAs in
vivo.
The initial RT-PCR experiments were performed non-
quantitatively on mixed-stage RNA preparations. We
subsequently used real-time quantitative RT-PCR (qRT-
PCR) to determine the relative expression levels of sma-9
variant transcripts and whether they are developmentally
or sex-specifically regulated. Since we expect full-length
transcripts, but not the short transcripts, to contain
sequences from exon 9, we used exon 9 internal primers
to determine the expression levels of potentially full-
length transcripts and calculated the abundance of the
short transcripts relative to exon-9-containing tran-
scripts. Three developmental time points were assayed:
24 hr (first larval stage - L1), 44 hr (approximately L3),
and 96 hr (adults). We find that exon-9-containing tran-
script levels increase during larval development and are
highest in adulthood (Figure 2B). D01 transcripts accu-
mulate in wild-type strain N2 at 45% - 85% of the level of
exon-9-containing transcripts at all developmental time
points examined, while A11 transcripts accumulate at
approximately 10% of the level of exon-9-containing tran-
scripts (Figure 2B; Table 1). If A11 and D01 are produced
concurrently by trans-splicing of full-length transcripts,
then the reduced accumulation of A11 may be due to dif-
Figure 1 Structure of sma-9 transcript variants. The predicted sma-9 intron-exon structure is shown above. Arrows mark positions of nonsense 
codons in three sma-9 alleles. pCS386 is the most complete cDNA variant isolated to date. The two short variants represented by cDNA clones 
yk1285a11 (A11) and yk1237d01 (D01) are shown below. ARD: acidic residue-rich domain; NLS: nuclear localization signal.
pCS368
Yin et al. BMC Molecular Biology 2010, 11:46
http://www.biomedcentral.com/1471-2199/11/46
Page 4 of 11
Figure 2 Expression of sma-9 transcript variants. A. Detection of A11 and D01 transcripts using variant-specific RT-PCR over a gradient of annealing 
temperatures (left to right: 50°C - 55°C). The expected size of the PCR product is 330 bp for A11 and 300 bp for D01. B. Developmental profile of sma-
9 transcript expression levels, as determined by qRT-PCR. Data are shown as transcript abundance relative to act-1 actin gene control, and error bars 
show standard deviation. See Table 1 for quantitation of transcript abundance relative to exon-9-containing control.
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ferential stability of the transcripts. One possible mecha-
nism for reduced stability of the A11 transcript is the
unusual location of the termination codon TAA, in which
the terminal adenines are introduced during polyadenyla-
tion and are contiguous with the poly(A) tail. To test for
sex-specific expression of these transcripts, him-5 (high
incidence of males) mutant populations that contain both
hermaphrodites and males were compared to wild-type
N2 hermaphrodite populations. In him-5 populations,
the full-length and the D01 transcripts, but not A11,
accumulate to a 2-4-fold higher level than in hermaphro-
dite populations, suggesting that these transcripts are
expressed at a higher level in males. The short transcripts
are not male-specific, however, since they are also
expressed in hermaphrodites. Thus, the A11 and D01
cDNA clones represent detectable mRNAs that are
expressed during larval and adult stages when DBL-1 is
active in regulating body size and male tail patterning.
Loss of function of sma-9 variant transcripts
Previous work has shown that sma-9 constructs lacking
the Zn finger triplet (ZF3-5) are unable to rescue the
body size and mesodermal patterning defects of a sma-9
mutant [14]. These experiments did not test, however, for
differential requirements of short vs. full-length tran-
scripts. To test whether sma-9 variant transcripts have
specific functional roles, we performed RNAi targeting
three different regions of the sma-9 gene. In previous
experiments, dsRNA was introduced by microinjection
[13,14], but we have found that RNAi by feeding results in
a higher penetrance of male tail defects. We have there-
fore repeated these experiments using the feeding tech-
nique [29], and extended them by targeting the internal
exon 9 in addition to the 5' and 3' ends of the gene. The
effectiveness of each RNAi treatment was monitored by
the appearance of the characteristic small body size phe-
notype (data not shown).
As a component in the DBL-1 pathway, sma-9 mutant
phenotypes include small body size and male abnormal
phenotypes [13]. One aspect of the male abnormal phe-
notype in sma-9 is the fusion of male tail sensory rays 8
and 9, two of the nine bilaterally symmetrical pairs of
male-specific sensory organs. In wild-type animals, ray 8-
9 fusions are also observed, but at a lower frequency.
Yin et al. BMC Molecular Biology 2010, 11:46
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Treatment of wild-type animals with RNAi targeting
exons 1-7 caused no increase in the frequency of ray 8-9
fusions (Table 2), although the small body size phenotype
was produced. This treatment is predicted to knockdown
expression of full-length and A11 variants but not the
D01 variant. Conversely, RNAi targeting exons 21-25,
predicted to knockdown the D01 and full-length variants,
resulted in a two-fold increase in the frequency of ray 8-9
fusions (Table 2). These results are consistent with our
previous findings that RNAi of the 3' end of the gene
results in more severe male abnormal phenotypes than
inactivation of the 5' end [13]. We next compared the
male tail phenotype produced by RNAi targeting the cen-
tral exon 9, predicted to inhibit full-length transcripts but
not the short transcripts. This treatment resulted in a
male tail defect of lower penetrance than that produced
by RNAi targeting the 3' end (Table 2). Since the most
severe male tail defect occurred when D01 was targeted,
these experiments suggest that D01 has a role in regulat-
ing sensory ray patterning. Full-length sma-9 products
are also predicted to function in sensory ray patterning,
since the inhibition of a central exon resulted in a partial
male abnormal phenotype.
We sought to repeat this analysis using genetic
mutants, since the RNAi treatments might cause some
nonspecific effects due to targeting of unspliced pre-
mRNA or to RNAi spreading [30,31]. We took advantage
of three sma-9 alleles containing premature termination
codons at different locations in the gene (Figure 1;
[13,14]): qc3 in predicted exon 1 (within A11), wk55 in
predicted exon 9 (between the short variants), and cc604
in predicted exon 18 (within D01). Therefore, in qc3, only
the D01 transcript is capable of encoding a functional
gene product; in wk55, both A11 and D01, but not the
full-length transcript, are capable of encoding functional
gene products; and in cc604, only the A11 transcript is
capable of encoding a functional gene product. Since
additional disruptions may occur due to nonsense-medi-
ated decay [32], we determined the transcript expression
profile for these strains at the L3 stage (Figure 3; Table 1).
In all three mutant backgrounds, the transcript levels are
somewhat reduced compared to the him-5 control. The
reduction in transcript levels is most striking in the sma-
9(wk55) background (Figure 3). This severe reduction in
transcript levels is consistent with our observations that
this allele causes the most severe body size phenotype
(Table 2; [13]). Most importantly for the interpretation of
our experiments, sma-9(qc3) and sma-9(cc604) animals
express the short transcripts at detectable levels near the
normal range (Figure 3).
The usual expectation for a series of nonsense muta-
tions is that the earliest premature termination codon will
have the most severe mutant phenotype while later ter-
mination codons may cause less severe defects if those
alleles encode partially functional gene products. For the
sma-9 alleles, the opposite result is seen in the male tail.
The allele encoding the latest termination codon, cc604,
causes the most severe male tail defect, with a frequency
of ray 8-9 fusions greater than any of the previously char-
acterized alleles (Table 2, [13]). Since different investiga-
tors typically vary in their quantitation of ray fusion
frequencies, we also repeated measurement of the male
Table 1: Relative expression levels of sma-9 transcript variants
Strain Developmental
Timepoint
A11 Transcript
Level
D01 Transcript
Level
N2 L1 10.12 ± 1.06 86.35 ± 1.17
N2 L3 8.88 ± 2.58 45.00 ± 0.87
N2 adult 8.97 ± 0.43 84.58 ± 7.82
him-5 L1 8.23 ± 0.28 87.01 ± 0.37
him-5 L3 2.18 ± 0.00 37.73 ± 0.11
sma-9(qc3);him-5 L3 6.20 ± 0.01 49.55 ± 1.29
sma-9(wk55);him-5 L3 1.81 ± 0.09 88.50 ± 1.32
sma-9(cc604);him-5 L3 9.40 ± 0.05 62.70 ± 1.26
Mean expression levels are give as percent of the expression level of exon-9-containing control, plus or minus standard deviation.
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tail defects of qc3 and wk55 for direct comparison. Con-
sistent with previous results, qc3, the allele containing the
earliest termination codon, causes a mild male tail defect,
while wk55, containing a termination codon in exon 9,
results in an intermediate frequency of ray fusions (Table
2). Thus, the severity of the sensory ray defect is inversely
correlated with predicted D01 activity. The most severe
defect is manifested in cc604 mutants, in which the D01
isoform is disrupted by mutation. An intermediate fre-
quency of ray fusions occurs in wk55 mutants, in which
the D01 transcript is expressed at reduced levels but is
not disrupted by mutation. A mild male tail defect is seen
in qc3 mutants, in which levels of D01 transcripts are
lower than in wild type but higher than in wk55 (Figure
3). Overall, with regard to male tail patterning, these
mutations form an allelic series in which their levels of
activity are the opposite of that expected.
In body size, a different result was obtained with these
three mutants (Table 2). The sma-9(wk55) mutant shows
the smallest body size. In contrast, both qc3 and cc604
produce less severe body length phenotypes that are
mutually indistinguishable (Table 2). Since qc3 and cc604
produce indistinguishable body size defects, this analysis
does not support a specific role for either the A11 or the
D01 transcript in the regulation of body size. Further-
more, the more severe body size phenotype of wk55
mutants could be due to the lower overall level of sma-9
expression in these mutants (Figure 3). The results of
body size analysis thus suggest that full-length isoforms,
rather than A11 or D01, are critical for promoting
growth. Based on our RNAi data and on the differential
effects of the three nonsense alleles on body size and male
tail development, we hypothesize that the D01 short tran-
script has a tissue-specific function in sensory ray devel-
opment.
Rescue of sma-9 mutant phenotypes by overexpression of 
D01 cDNA
Consistent with our hypothesis, we have previously dem-
onstrated that overexpression of the D01 cDNA, but not
of A11, from a heat shock promoter can partially rescue
sma-9(wk55) mutant male tail defects [33]. In compari-
son, expression of sma-9 from a cosmid genomic clone
containing the entire coding region resulted in nearly
complete rescue of the ray fusion defect [13]. We next
asked whether expression of sma-9 short transcripts is
sufficient to provide normal gene function in qc3 and in
cc604 mutants, in which the A11 and the D01 transcript,
respectively, are disrupted by premature termination
codons. As before, transgenics carrying hs-sma-9 con-
structs were subjected to heat shock during the L3 stage
when sensory ray identities are being established [34] and
males were scored in adulthood. In cc604 mutants, which
contain a premature termination codon within the D01
transcript, expression of D01 resulted in partial rescue of
the male tail defect (Figure 4A). In contrast, overexpres-
sion of A11 in cc604 caused a slight reduction in fre-
quency of sensory ray fusions, but this effect was not
statistically significant (p = 0.16). In qc3 mutants, in
which the A11 transcript contains a premature termina-
tion codon, we were surprised to find that overexpression
of A11 produced no change in male tail phenotype,
whereas overexpression of D01 resulted in significant res-
cue of the male tail defect (Figure 4A). Based on the res-
Table 2: sma-9 loss of function phenotypes in male tail patterning and body size
RNAi (Exon) or Mutant Forms Predicted to be Blocked Frequency of Ray 8-9 Fusions1 (n) Body Length2 (n)
none none 18% (50) ND
1-7 full-length, A11 20% (50) ND
9 full-length only 29% (100) ND
21-25 full-length, D01 36% (50) ND
sma-9(qc3) full-length, A11 50% (50) 692 ± 85 (43)
sma-9(wk55) full-length only 66% (50) 566 ± 34 (31)
sma-9(cc604) full-length, D01 72% (50) 716 ± 61 (30)
1All male tail phenotypes are scored with him-5(e1490) in the background to increase the frequency of males.
2Body length is given in μm ± standard deviation at 96 hours after embryo collection.
ND: not determined.
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cue of male tail defects by D01 in both qc3 and cc604
mutants, we conclude that increased expression of D01
may be able to compensate partially for defective full-
length sma-9 transcripts.
Finally, we looked for evidence of A11 or D01 function
in body size regulation. The body size phenotypes of qc3
and cc604 did not support a specific role for either A11 or
D01 in body size regulation, since these two mutants have
indistinguishable sizes (Table 2). To determine whether
increased expression of A11 and/or D01 can promote
growth, we used our heat shock constructs to drive their
expression. Heat shock of transgenics in the L3 stage pro-
duced no evident changes in body size (data not shown),
so we performed heat shock earlier in development, in L1
animals, and measured body length in adulthood. In con-
trast to the rescue of male abnormal phenotypes by D01,
heat shock of A11 and D01 transgenics led either to a
reduction in body size or to no change in body size (Fig-
ure 4B). These results suggest that A11 and D01 do not
contribute to the growth promoting activity of sma-9. If
anything, increased expression of A11 and D01 may
interfere with the ability of gene products from full-
length transcripts to promote increases in body size.
Discussion
We have shown here that the C. elegans sma-9/schnurri
locus undergoes a novel trans-splicing process to gener-
ate two shorter transcripts, one of which has a tissue-spe-
cific function in DBL-1/BMP signaling. First, we have
demonstrated that an SL2 trans-spliced, truncated cDNA
form, yk1237d01 (D01), represents an actual mRNA that
is detectable by RT-PCR. Second, we have verified that
longer transcripts containing both the 5' and 3' ends of
the gene are also detectable by RT-PCR. Third, loss-of-
function experiments (RNAi and premature termination
mutants) demonstrate that the short transcript D01 is
necessary but not sufficient for male tail patterning, since
depletion of both D01 and full-length transcripts causes a
more severe male tail patterning defect than depletion of
full-length transcripts alone. Fourth, gain-of-function
experiments (heat shock-induced overexpression) indi-
cate that the short transcript D01 can partially rescue
Figure 3 Expression levels of sma-9 transcripts in mutant backgrounds. Expression levels of sma-9 transcripts as determined by qRT-PCR. Animals 
were collected at the L3 stage. Data are shown as transcript abundance relative to act-1 actin gene control, and error bars show standard deviation. 
See Table 1 for quantitation of transcript abundance relative to exon-9-containing transcripts. (-): transcript harbors a premature termination codon. 
(+): transcript sequence is normal.
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male tail but not body size defects of sma-9 mutants. In
contrast to the results on D01, we find for the yk1285a11
(A11) transcript little or no evidence of an in vivo func-
tion, as well as low abundance throughout development.
In addition, class I and II full-length transcripts and the
D01 short transcript, but not the A11 transcript, encode
the Zn finger triplet domain shown to be critical in the
regulation of body size and mesodermal patterning [14].
In Drosophila, this domain is also critical in mediating
Dpp-responsive target gene regulation [35]. The gene
product encoded by the A11 transcript lacks this domain
and may therefore not be capable of being recruited to
target genes. Why then is the A11 transcript detected at
all? One possibility is that it is generated as a byproduct
of the trans-splicing mechanism that generates D01.
Since we have shown that full-length transcripts and
D01 transcripts are each necessary but not sufficient for
male tail patterning, we must consider what differences in
molecular function are found in the respective gene prod-
ucts. In other organisms, Schnurri homologs have been
shown to act either as transcriptional activators
[20,21,36] or as transcriptional repressors [16,37] mediat-
ing BMP-dependent transcription. Strikingly, Yao et al.
[21] have shown by swapping Drosophila and Xenopus
Schnurri homologs that transcriptional activation or
repression activities may be context-dependent rather
than an intrinsic property of the protein. In C. elegans, we
have previously analyzed intrinsic transcriptional activi-
ties of SMA-9 protein domains using a heterologous tran-
scription assay [33]. In these experiments, the acidic
residue-rich domain (ARD) in exon 14 exhibited tran-
scriptional activator activity, while the N-terminal region
of SMA-9 displayed intrinsic transcriptional repressor
activity [33]. Full-length sma-9 transcripts should encode
protein products containing both of these transcriptional
domains, so that their transcriptional activities may be
context-dependent as was described for Drosophila and
Xenopus Schnurri [21]. On the other hand, D01 tran-
scripts encode products containing solely the transcrip-
tional activation domain (Figure 1). We therefore
hypothesize that full-length SMA-9 isoforms function as
transcriptional repressors or activators depending on
context, while D01-encoded isoforms may be obligate
transcriptional activators. This transcriptional activation
activity may be necessary for the robust activation of
sma-9 target genes in sensory ray development, but may
be dispensable in body size regulation. Consistent with
this hypothesis, a SMA-9 Zn finger domain fusion with a
known transcriptional activator, VP16, can partially res-
cue the male tail defects but not the body size defects of
sma-9 mutants. In contrast to the SMA-9::VP16 fusion, a
SMA-9::enR repression domain fusion rescues body size,
suggesting that transcriptional repression is more impor-
tant than activation for SMA-9 activity in body size regu-
lation [33]. Overall, the in vivo activity of the SMA-
9::VP16 fusion is strikingly similar to that of the D01 iso-
form.
Alternative splicing is regulated by trans-acting factors
that influence the choice of splice sites. It will be of inter-
est to determine the trans-acting factors that regulate
alternative trans-splicing of sma-9. In preliminary experi-
ments, we tested whether sma-9 trans-splicing depends
on mec-8, which encodes an RNA recognition motif-con-
taining protein that regulates alternative splicing in the
hypodermis [38,39]. We found that A11, D01, and exon 9-
containing transcript levels were all reduced 2- to 5-fold
in mec-8 mutants relative to N2 (data not shown). If mec-
8 were directly involved in processing the short tran-
Figure 4 Phenotypic rescue by overexpression of sma-9 short transcripts. A. Male tail phenotypes are given as frequency of fusion of rays 8 and 
9 per male tail side scored. p values were calculated using a Student's t-test. *: significant difference from no cDNA control (p < 0.05). **: highly signif-
icant difference from no cDNA control (p < 0.01). The p values for experiments with A11 cDNA overexpression showed no significant difference from 
controls (p = 0.59 for qc3; p = 0.16 for cc604). All strains contain him-5(e1490) to increase the proportion of males. B. Body size phenotypes. Mean body 
length at 96 hours after embryo collection (adult stage) is shown. Error bars show standard deviation. Note that these strains are transgenics express-
ing the rol-6 marker that influences body length, so all comparisons are made between heat-shocked animals and no heat shock control rather than 
using a nontransgenic control. p values were calculated using a Student's t-test. **: highly significant difference from no heat shock control (p < 0.01).
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scripts from a longer precursor, we expected to find
reciprocal changes in accumulation of the full-length
transcripts relative to short transcripts. Our results are
therefore not sufficiently clear to draw a conclusion as to
whether MEC-8 is directly involved in sma-9 trans-splic-
ing, and additional investigations will be necessary to
identify the trans-acting factors that mediate this reac-
tion.
A variety of genetic mechanisms exist for generating
diverse functions from a single genetic locus, including
those that affect transcript structure such as alternative
splicing, alternative transcriptional start sites, and alter-
native polyadenylation. One prominent example of alter-
native splicing is the regulation of sex determination in
Drosophila by Sex-lethal [40]. This system also uses
developmentally regulated alternative promoters. In C.
elegans, extensive use of alternative promoters leading to
different protein isoforms has been documented [41].
Alternative polyadenylation can also lead to the produc-
tion of truncated protein variants, such as in the daf-4
BMP receptor gene in C. elegans, in which alternative
polyadenylation leads to the production of a secreted
negative inhibitor of DAF-4 signaling [42]. To our knowl-
edge, alternative trans-splicing as we have characterized
it for sma-9 has not previously been reported for other
loci in C. elegans. The unique feature of this trans-splic-
ing event is the choice between processing the transcript
via cis- or trans-splicing at the splice acceptor site of pre-
dicted exon 11. In an organism without trans-splicing, a
similar truncation could be achieved via use of a down-
stream transcriptional start site or via proteolytic cleav-
age. For example, in the Hedgehog signaling pathway,
full-length transcription factors of the Ci/Gli family are
transcriptional activators that, upon proteolytic cleavage,
are converted to transcriptional repressors [43]. We spec-
ulate that since the trans-splicing machinery exists in C.
elegans, it was available to be recruited for this unusual
role in the sma-9 locus.
Conclusions
Both C. elegans sma-9/schnurri [13] and the human
homologs Shn-1 and Shn-3 [23,24] display alternative
splicing that is predicted to result in multiple protein iso-
forms. For most of these isoforms, however, no specific in
vivo function has been described. We have now demon-
strated a functional role for an alternatively trans-spliced
sma-9 short transcript represented by cDNA clone
yk1237d01 (D01). This transcript mediates a tissue-spe-
cific role, since it is required for sensory ray development
but not for body size regulation. Our results provide
insight into how a single genetic locus can contribute to
diverse protein functions.
Methods
C. elegans strains and culture
Nematodes were cultured using standard methods and
grown at 20°C unless otherwise noted [44]. In addition to
strains generated in this work, the following strains were
used: N2 (wild type); LG V, him-5(e1490); LG X, sma-
9(qc3, wk55, cc604).
RT-PCR
RT-PCR was performed in two steps using SuperScript
III First-Strand Synthesis System (Invitrogen) and RNA
extracted from mixed-stage N2 wild-type animals. Tem-
perature gradient PCR was performed on an Eppendorf
gradient thermal cycler (MasterCycler) following the
manufacturer's instructions.
Real time RT-PCR was performed on a LightCycler 2.0
(Roche). Data analysis software used was LightCycler
software version 4.0. Animals were collected at desired
time points and total RNA extracted by Trizol as
described [13]. SuperScriptTM III platinum two-step
qRT-PCR kit with SYBR Green (Invitrogen) was used to
perform RT-PCR. Actin gene act-1 was used as standard
control. A primer in an intron of the act-1 gene was used
to confirm the absence of genomic DNA in RNA preps.
Primer sequences for all RT-PCR experiments are avail-
able upon request.
RNAi
RNAi feeding method was performed as described [29]
after cloning sma-9 fragments into RNAi feeding vector
pPD129.36 (a gift from Dr. A. Fire). To score sensory ray
patterning, only adult males displaying a small phenotype
were collected and scored to ensure that the animals ana-
lyzed had undergone a knockdown of sma-9 activity.
Heat-shock clone constructs and generation of transgenic 
animals
Two sma-9 splice variants yk1285a11 and yk1237d01
(GenBank Accession Numbers: AY390537 and
AY390550) were identified previously [13], which were
SL1- and SL2- trans-spliced cDNA clones that appeared
to represent shorter but complete mRNAs. Heat-shock
vector pPD49.83 was a kind gift from Dr. J. Liu.
yk1285a11 and yk1237d01 were cloned into pPD49.83 at
Nhe I and Kpn I sites. Transgenic nematodes were gener-
ated by microinjection of constructs (10 ng/ul) into the
gonadal syncytia of him-5 hermaphrodites, with rol-6
(100 ng/ul) as a marker [45]. Mutant strains carrying
transgenic constructs were generated by appropriate
crosses between the mutant strains and transgenic lines.
Heat-shock experiments
Gravid hermaphrodites were washed off plates with M9
buffer and collected in an Eppendorf tube. Hermaphro-
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dites were destroyed with sodium hypochlorite solution,
leaving eggs that were collected and inoculated onto
OP50-seeded plates. For body size measurement, 24
hours after egg collection, worms were collected and
transferred to a siliconized Eppendorf tube containing
100 ul of M9 buffer [44], which was placed in a circulating
water bath under the heat-shock conditions specified.
After heat-shock, worms were recovered, placed at 25°C
on OP50-seeded plates and allowed to develop to adult-
hood. The length of individual worms was measured
using Image-Pro Express software (Sigma) with Nomar-
ski optics. For male tail ray examination, worms were col-
lected 72 hours after egg collection and transferred to a
siliconized Eppendorf tube containing 100 ul of M9 buf-
fer [44], which was placed in a circulating water bath
under the heat-shock conditions specified. After heat-
shock, worms were recovered, placed at 25°C on OP50-
seeded plates and allowed to develop to adulthood and
then scored for ray patterning.
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